(Q46875163)

26 December 2017

title

Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture (English)

1 reference

26 December 2017

feline infectious peritonitis

0 references

1 reference

1 reference

1 reference

8

1 reference

26 December 2017

Els Keyaerts

Els Keyaerts

2

0 references

Erik De Clercq

Erik De Clercq

6

0 references

Jan Balzarini

1

Jan Balzarini

1 reference

26 December 2017

3

Leen Vijgen

1 reference

26 December 2017

Miguel Stevens

5

Miguel Stevens

1 reference

26 December 2017

Herman Egberink

7

Herman Egberink

1 reference

26 December 2017

author name string

Frank Vandermeer

4

1 reference

26 December 2017

language of work or name

English

0 references

publication date

30 December 2005

1 reference

26 December 2017

Journal of Antimicrobial Chemotherapy

published in

1 reference

26 December 2017

volume

57

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

472-481

1 reference

26 December 2017

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

A novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

Coronavirus as a possible cause of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

SARS-Associated Coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

The Genome sequence of the SARS-associated coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

Proliferative growth of SARS coronavirus in Vero E6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

Role of interferons in the treatment of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

Inhibition of human immunodeficiency virus by a new class of pyridine oxide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

Novel human immunodeficiency virus (HIV) inhibitors that have a dual mode of anti-HIV action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

Pyridine N-oxide derivatives: unusual anti-HIV compounds with multiple mechanisms of antiviral action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI481

Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16387746

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JAC/DKI481

1 reference

26 December 2017

PMC publication ID

7110042

0 references

1 reference

26 December 2017